
How Has Neurological Telemedicine Fared Amid COVID-19?
The effectiveness of telemedicine services among patients with neurological conditions was spotlighted amid the coronavirus disease 2019 (COVID-19) pandemic, particularly how telephone and video consultations have fared in temporarily replacing face-to-face consultations.
Amid the coronavirus disease 2019 (COVID-19) pandemic,
“Two main reasons probably accounted for this lack of uptake: first, there was no incentive to change practice; and second, a fear prevailed that practising telemedicine might not quite be legal,” explained Patterson.
Now in 2020, Patterson writes that neurologists worldwide have started using various types of
Past research on telemedicine in neurology (teleneurology) has shown it could replicate everything that would be achieved via face-to-face consultation for conditions from coma to headache, with additional cost savings and positive reviews from patients.
Seeking to examine the comparable efficacy of both health care delivery approaches, Patterson reviewed “short clinical pieces” assessing teleneurology in the past year. One
Examined over a 11-week period, patients’ rooms were provided access to videolinks that allowed a majority of “checking” visits to be completed remotely. In the investigators’ findings, this approach was shown to save PPE costs from the 3508 virtual visits made, which Patterson says is an example of the second primary reason to use telemedicine, cost-saving advantages over face-to-face medicine.
Another
In concluding, Patterson notes a lack of research this year on asynchronous teleneurology using email, web servers, or smartphone applications, which he says can provide a big advantage over real-time methods and can save neurologists time.
“Perhaps their potential will be realized in coming years as well as further applications of synchronous teleneurology now that many more neurologists all over the world are using these approaches.”
Reference
Patterson V. Neurological telemedicine in the COVID-19 era. Nature Reviews Neurology. Published November 30, 2020. doi:10.1038/s41582-020-00438-9
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.